Strong Balance SheetKVK's low leverage and high equity ratio provide long-term financial flexibility: the company can fund R&D, manage regulatory cycles, and withstand demand shocks without heavy refinancing. Healthy ROE signals effective use of capital that supports sustainable shareholder returns.

Stable Margins And Cost ManagementConsistently robust gross margins and stable operating margins point to durable cost controls and manufacturing efficiency. For a generics/specialty drug maker, persistent margin stability supports reinvestment in quality and incremental product development over multiple quarters.

Improving Cash GenerationRising operating cash flow and improved free cash flow enhance KVK's ability to self-fund capex and R&D, reduce reliance on external capital, and pay dividends. Strong cash conversion underpins long-term strategic initiatives and resilience through industry cycles.

Bears Say

Recent Revenue SlowdownA recent dip after years of growth suggests emerging demand or competitive pressures in core products. If persistent, this could constrain scale advantages and slow revenue-driven margin expansion, necessitating product or market diversification to restore trend growth.

FCF Conversion And Capex EfficiencyAlthough free cash flow improved, suboptimal FCF-to-net-income indicates capex or working-capital drag. Over time, inefficient capex deployment can weaken cash returns and limit funds available for new product development or strategic partnerships.

Modest Organic Growth RatesSingle-digit revenue and EPS growth imply slow organic expansion versus higher-growth peers. Persistent modest growth may limit scalability benefits and reduce the company's ability to broaden therapeutic presence without M&A or accelerated R&D productivity improvements.

6484 FAQ

What was KVK Corporation’s price range in the past 12 months?

KVK Corporation lowest stock price was ¥1752.00 and its highest was ¥2774.00 in the past 12 months.

What is KVK Corporation’s market cap?

KVK Corporation’s market cap is ¥20.46B.

When is KVK Corporation’s upcoming earnings report date?

KVK Corporation’s upcoming earnings report date is May 18, 2026 which is in 89 days.

How were KVK Corporation’s earnings last quarter?

KVK Corporation released its earnings results on Feb 13, 2026. The company reported ¥60.73 earnings per share for the quarter, beating the consensus estimate of N/A by ¥60.73.

Is KVK Corporation overvalued?

According to Wall Street analysts KVK Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does KVK Corporation pay dividends?

KVK Corporation pays a Semiannually dividend of ¥40 which represents an annual dividend yield of 3.46%. See more information on KVK Corporation dividends here

What is KVK Corporation’s EPS estimate?

KVK Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KVK Corporation have?

KVK Corporation has 8,322,178 shares outstanding.

What happened to KVK Corporation’s price movement after its last earnings report?

KVK Corporation reported an EPS of ¥60.73 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.079%.

Which hedge fund is a major shareholder of KVK Corporation?

Currently, no hedge funds are holding shares in JP:6484

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

KVK Corporation

KVK Corporation manufactures and sells faucets in Japan. It offers bathroom, kitchen, and sink fixtures; pipes and pipe fittings; and other faucet parts. KVK Corporation was founded in 1939 and is headquartered in Gifu, Japan.